ProPublica published a list of investigations you may have missed due to America's governing turmoil. One is the story of Zolgensma, a gene therapy drug which gives baby's born with a rare disease a real chance to grow up and live normal lives. Despite being developed with help from taxpayers and nonprofit charities, the drug's maker debuted the drug with a $2-million per dose price tag, which set the stage for other gene therapy drugs to also have million dollar prices. ProPublica dug into the records to show how the drug was developed and why it debuted at such a high cost. "Its story upends the widely held conception that high prices reflect huge industry investments in innovation."
Drudge Retort Headlines
ICE Is Now Breaking Into Homes of American Citizens (68 comments)
Globe Flees U.S. Assets, Treasury Prices Tumble (49 comments)
Man Accused of Aiming Laser at Trump Helicopter Acquitted in 35 Minutes (39 comments)
A Day of MAGA Meals will Cost $15.64 (33 comments)
Trump Confuses Iceland and Greenland Multiple Times (28 comments)
'Melania' Headed for Empty Seats and Low Streams (20 comments)
Trump Threatens 200% Tariff in 'Board of Peace' Push (20 comments)
Greenland PM Tells People to Prepare for Possible Invasion (20 comments)
A look at Trump's Board of Peace (19 comments)
Judge Limits ICE Tactics at Minnesota Protests (19 comments)